A Phase 2a, Randomised, Double Blind, Placebo-Controlled Study of IMR-687 in Adult Patients with Sickle Cell Anaemia (Homozygous HbSS or Sickle-B thalassemia.
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Imara, Inc.
Start Date
November 12, 2019
End Date
September 30, 2020
Administered By
Medicine, Hematology
Awarded By
Imara, Inc.
Start Date
November 12, 2019
End Date
September 30, 2020